Effect of non-surgical periodontal therapy on risk markers of cardiovascular disease: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index; 16 of the 40 sources its claims cite were checked for support.
Abstract
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of mortality in the world. Patients with periodontitis have a higher risk of CVD, although a causal relationship between these conditions remains unclear. Non-surgical periodontal therapy (NSPT) is able to control inflammation at local and systemic levels. This study aimed to analyze the effect of NSPT on CVD risk markers. METHODS: Four electronic databases were searched from their inception to April 1, 2023, to identify and select articles without any language restrictions. Eleven CVD-related markers (e.g., C-reactive protein [CRP], Interleukin-6 [IL-6]) were selected. Meta-analyses were performed using random and fixed effect models. The differences were expressed as weighted mean differences (WMD) and 95% confidence interval (95% CI). RESULTS: From 1353 studies, twenty-one randomized controlled clinical trials were included in the meta-analysis. Results showed a significant decrease in CRP, IL-6, and systolic blood pressure (SBP) after NSPT. CONCLUSION: Moderate certainty evidence shows that NSPT has a positive effect on the reduction of IL-6 and SBP in patients with periodontitis, while low certainty evidence shows that NSPT is effective for reduction of CRP. Moderate certainty evidence showed that NSPT did not show a positive effect on low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol (TC) and triglycerides (TG), and low certainty evidence showed that NSPT did not show a positive effect on Interleukin-1β (IL-1β), tumor necrosis factor-alpha (TNF-α), diastolic blood pressure (DBP), and flow-mediated dilatation (FMD). PROTOCOL REGISTRATION: The protocol was registered in the PROSPERO (International Prospective Register of Systematic Reviews), number CRD42022377565.
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis of 21 RCTs found that non-surgical periodontal therapy significantly reduced CRP, IL-6, and systolic blood pressure in patients with periodontitis, but not other CVD risk markers. Certainty was moderate for IL-6 and SBP and low for CRP.
Key findings
- From 1353 records, 21 RCTs were included. NSPT significantly decreased CRP (WMD −0.63 mg/L, 95% CI −1.02 to −0.24, P < 0.01; I² = 66%) and IL-6 (WMD −0.73 pg/mL, 95% CI −0.89 to −0.57, P < 0.01; I² = 30%).
- NSPT significantly reduced SBP (WMD −7.85 mmHg, 95% CI −12.77 to −2.94, P < 0.01), but not DBP (WMD −4.25 mmHg, 95% CI −8.72 to 0.22, P = 0.06) or FMD (1.70%, 95% CI −1.63 to 5.03, P = 0.32).
- No significant changes were found for IL-1β (WMD −0.24 pg/mL, 95% CI −0.81 to 0.33, P = 0.40), TNF-α (WMD −0.68 pg/mL, 95% CI −1.64 to 0.28, P = 0.16), LDL (−0.10 mM, 95% CI −0.21 to 0.01, P = 0.09), HDL (0.04 mM, 95% CI 0.00 to 0.08, P = 0.06), TC (0.06 mM, 95% CI −0.07 to 0.18, P = 0.38), or TG (−0.08 mM, 95% CI −0.19 to 0.04, P = 0.18).
- Certainty was moderate for IL-6, SBP, LDL, HDL, TC, and TG, and low for CRP, IL-1β, TNF-α, DBP, and FMD. Subgroup analyses suggested CRP reduction was significant in CVD patients (1.20 mg/L) and showed a similar trend in metabolic disorders, but not in otherwise healthy periodontitis patients.
Methods
- Systematic review and meta-analysis of RCTs, registered in PROSPERO (CRD42022377565) and reported per PRISMA. PubMed, Embase, Cochrane Library, and Web of Science were searched from inception to April 1, 2023, without language restrictions.
- Twenty-one RCTs published 2003–2021 from 10 countries were included. Participants had periodontitis; intervention was NSPT (supra- and subgingival instrumentation with or without adjunctive antiseptic/antibiotics) versus no treatment, oral hygiene instructions only, or control periodontal therapy. Outcomes included CRP, IL-6, IL-1β, TNF-α, TC, TG, LDL, HDL, SBP, DBP, and FMD.
- Meta-analyses used random- or fixed-effects models based on heterogeneity, expressed as WMD with 95% CI; I² assessed heterogeneity. Subgroup analyses examined systemic health status, adjunctive antiseptic/antibiotic use, and follow-up time; sensitivity analyses, Egger’s test/funnel plots, and GRADE certainty assessment were also performed.
Limitations
- The paper states moderate to large heterogeneity for most outcomes, attributed to varying diagnostic criteria, periodontitis severity, smoking status, and intervention procedures; confounding factors such as BMI, smoking, and gender could not be further analyzed because standards could not be unified.
- The paper states that IL-1β, TNF-α, SBP, DBP, and FMD analyses included a limited number of studies, so results should be interpreted cautiously; publication bias was suggested for CRP (Egger’s test P = 0.02).
- Risk of bias was low in 10 studies, some concerns in 10, and high in 1; main concerns were randomization, blinding of participants/personnel, and loss to follow-up.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
10 Valid · 2 Not valid · 11 Not checked · 61 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Additionally, there is evidence from various studies that individuals with periodontitis have a higher prevalence of subclinical CVD, which is characterized by significant arterial stiffness (assessed by pulse wave velocity [PWV]) [20] and endothelial dysfunction [21].”
§ Effect of non-surgical periodontal therapy on risk markers of cardiovascular disease: a systematic review and meta-analysis > Introduction
What the sources say
- Not checked — no full text of the sourcecites [20] Schmitt A, Carra MC, Boutouyrie P, Bouchard P. Periodontitis and arterial stiffness: a systematic review and meta-analysis. J Clin Periodontol. 2015;42(11):977–87. source
- Disputedcites [21] Holtfreter B, Empen K, Gläser S, Lorbeer R, Völzke H, Ewert R, Kocher T, Dörr M. Periodontitis is associated with endothelial dysfunction in a general population: a cross-sectional study. PLoS ONE. 2013;8(12):e84603. sourceExperimental — accuracy not yet measured
The citation to this paper is attached to the endothelial-dysfunction part of the sentence, not the PWV finding. Although the Introduction describes earlier studies reporting impaired endothelial function in patients with periodontitis, this paper’s Results and Discussion report the opposite direction in its general-population sample: more severe periodontal disease was associated with higher flow-mediated dilation, a measure of endothelial function. No page numbers are provided in our copy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Patients with severe periodontitis had higher blood neutrophil counts and pro-inflammatory mediator levels (such as IL-1, IL-6, CRP, and fibrinogen) compared to healthy controls [14–17]”
§ Effect of non-surgical periodontal therapy on risk markers of cardiovascular disease: a systematic review and meta-analysis > Introduction
What the sources say
- Not matchedcites [14] D’Aiuto F, Orlandi M, Gunsolley JC. Evidence that periodontal treatment improves biomarkers and CVD outcomes. J Clin Periodontol. 2013;40(Suppl 14):S85–105.
More than one paper fits this citation.
- Not checked — no full text of the sourcecites [15] Genco RJ, Van Dyke TE. Prevention: reducing the risk of CVD in patients with periodontitis. Nat Rev Cardiol. 2010;7(9):479–80. source
- Partly supportedcites [16] Sanz M, Marco Del Castillo A, Jepsen S, Gonzalez-Juanatey JR, D’Aiuto F, Bouchard P, Chapple I, Dietrich T, Gotsman I, Graziani F, et al. Periodontitis and cardiovascular diseases: Consensus report. J Clin Periodontol. 2020;47(3):268–88. sourceExperimental — accuracy not yet measured
The Mechanisms sections report higher CRP and fibrinogen versus healthy controls, elevated serum IL-6, and excess IL-1β release by stimulated neutrophils in periodontitis patients. They describe neutrophil hyper-responsiveness, not higher blood neutrophil counts, and do not establish these findings specifically for severe periodontitis. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [17] Schenkein HA, Papapanou PN, Genco R, Sanz M. Mechanisms underlying the association between periodontitis and atherosclerotic disease. Periodontol 2000. 2020;83(1):90–106. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent research also found a relationship between periodontitis and hypertension [22, 23].”
§ Effect of non-surgical periodontal therapy on risk markers of cardiovascular disease: a systematic review and meta-analysis > Introduction
What the sources say
- Not matchedcites [22] D’Isidoro O, Perrotti V, Hui WL, Piattelli A, Iaculli F, Quaranta A. The impact of non-surgical therapy of periodontal disease on surrogate markers for cardiovascular disease: a literature review. Am J Dent. 2019;32(4):191–200.
Its entry has no title and year that we can search by.
- Supportedcites [23] Muñoz Aguilera E, Suvan J, Buti J, Czesnikiewicz-Guzik M, Barbosa Ribeiro A, Orlandi M, Guzik TJ, Hingorani AD, Nart J, D’Aiuto F. Periodontitis is associated with hypertension: a systematic review and meta-analysis. Cardiovasc Res. 2020;116(1):28–39. source
The Discussion states that the systematic review supports a positive association between periodontitis and hypertension. This supports the citing sentence’s claim of a relationship without implying that one causes the other. (LLM, conf=0.95)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In contrast, the majority of previously relevant meta analyses only included periodontitis patients with specific systemic health conditions, such as CVD [75], CAD [76], hypertension [77] and diabetes [78].”
§ Effect of non-surgical periodontal therapy on risk markers of cardiovascular disease: a systematic review and meta-analysis > Discussion > Comparison with other studies
What the sources say
- Supportedcites [75] Roca-Millan E, González-Navarro B, Sabater-Recolons MM, Marí-Roig A, Jané-Salas E, López-López J. Periodontal treatment on patients with cardiovascular disease: systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2018;23(6):e681–90. source
This citation is attached to the CVD example, not to the separate CAD, hypertension, and diabetes examples. The Material and Methods section says the review excluded studies including patients without cardiovascular disease, and the Results section reports that it analyzed 10 trials involving patients diagnosed with cardiovascular disease. The source therefore supports its use as an example of a meta-analysis focused on periodontitis patients with a specific systemic condition. (LLM, conf=0.93)
- Supportedcites [76] Liu C, Shi F, Li W, Chen J. Efficacy of non-surgical periodontal treatment on patients with coronary artery disease: a meta-analysis of randomized controlled trials. Med Oral Patol Oral Cir Bucal. 2022;27(6):e578–87. source
The [76] citation identifies a meta-analysis restricted to periodontitis patients with CAD, not the separate examples of CVD, hypertension or diabetes. The Material and Methods section specifies that eligible trials studied patients diagnosed with both CAD and periodontitis. (LLM, conf=0.94)
- Partly supportedcites [77] Sharma S, Sridhar S, McIntosh A, Messow CM, Aguilera EM, Del Pinto R, Pietropaoli D, Gorska R, Siedlinski M, Maffia P, et al. Periodontal therapy and treatment of hypertension-alternative to the pharmacological approach. A systematic review and meta-analysis. Pharmacol Res. 2021;166:105511. sourceExperimental — accuracy not yet measured
Our copy of Sharma et al. (2021) is essentially the publisher/Pure record: the title ('Periodontal therapy and treatment of hypertension... A systematic review and meta-analysis'), the abstract's AIM line (effects of intensive vs conventional periodontal treatment on arterial blood pressure, endothelial function and inflammatory/metabolic biomarkers) and the keywords (Hypertension/etiology, Periodontitis/complications, Antihypertensive Agents/therapeutic use) confirm it IS a meta-analysis addressing periodontitis patients in the hypertension setting, which is the part the citation is offered for. What our copy nowhere states is the claim's restricting qualifier that such meta-analyses 'only included' patients with that specific systemic condition — no inclusion-criteria or study-population text is present. Searches for 'inclusion criteria/eligibility participants with hypertension', 'previous meta-analyses cardiovascular disease diabetes', and 'CONCLUSION reduced systolic blood pressure in hypertensive patients' returned only the same metadata/abstract fragments. (LLM, conf=0.70)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In atherothrombotic tissues, periodontal inflammation and viable bacteria have been found [18, 83, 84].”
§ Effect of non-surgical periodontal therapy on risk markers of cardiovascular disease: a systematic review and meta-analysis > Discussion > Potential mechanisms
What the sources say
- Not checked — no full text of the sourcecites [18] Herrera D, Molina A, Buhlin K, Klinge B. Periodontal diseases and association with atherosclerotic disease. Periodontol 2000. 2020;83(1):66–89. source
- Partly supportedcites [83] Reyes L, Herrera D, Kozarov E, Roldán S, Progulske-Fox A. Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology. J Clin Periodontol. 2013;40(Suppl 14):S30–50. sourceExperimental — accuracy not yet measured
Our copy supports the viable-bacteria half of the claim: the section 'Evidence of live periodontal bacteria at the affected site' reports Kozarov et al. (2005) evidence of live P. gingivalis and A. actinomycetemcomitans in atheromatous tissue and Rafferty et al. (2011) isolation of P. gingivalis, concluding that 'there is evidence that live periodontal bacteria are present in at least some atheromas' (also Discussion, Proof 3), though it hedges that no confirmatory reports exist and that 'visual proof of bacteria inside cells in the atheromas is still lacking' (Discussion, Proof 2). The 'periodontal inflammation found in atherothrombotic tissues' element is not stated: the paper treats the atherosclerotic lesion as 'a common inflammatory response to multiple factors' (Evaluation of the evidence) and describes periodontal bacteria provoking pro-inflammatory signalling (Overview of cardiovascular disease pathology; Proposal of a model/Fig. 2), i.e. inflammation as a mechanism, not as periodontal inflammation detected in the tissue. The tissue is described throughout as atheromatous plaque/atheroma rather than atherothrombotic. (LLM, conf=0.78)
- Partly supportedcites [84] Rafferty B, Jönsson D, Kalachikov S, Demmer RT, Nowygrod R, Elkind MS, Bush H Jr., Kozarov E. Impact of monocytic cells on recovery of uncultivable bacteria from atherosclerotic lesions. J Intern Med. 2011;270(3):273–80. sourceExperimental — accuracy not yet measured
The Results (page not available) report bacterial colonies recovered from atherectomy specimens and identify P. gingivalis in atherosclerotic plaque, supporting the finding of viable bacteria. The Discussion (page not available) says P. gingivalis is associated with periodontal inflammation, but does not report finding periodontal inflammation in the vascular tissue. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
51 more claims · 1 with their cited sources checked
Create a free account to see all 84 claims and to verify the 5 references still open.
- Probably not a substantial claim. 17
- It may state two separate claims as one. 17
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Effect of non-surgical periodontal therapy on risk markers of cardiovascular disease: a systematic review and meta-analysis > Discussion > Comparison with other studies
“In line with our findings, a meta-analysis published in 2022 confirmed a statistically significant reduction in SBP after NSPT vs. CPT among periodontitis patients [22].”
§ Effect of non-surgical periodontal therapy on risk markers of cardiovascular disease: a systematic review and meta-analysis > References
“22. D’Isidoro O, Perrotti V, Hui WL, Piattelli A, Iaculli F, Quaranta A. The impact of non-surgical therapy of periodontal disease on surrogate markers for cardiovascular disease: a literature review. Am J Dent. 2019;32(4):191–200. 31436940”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Effect of non-surgical periodontal therapy on risk markers of cardiovascular disease: a systematic review and meta-analysis > Discussion > Comparison with other studies
“while others reported a similar lack of effect to our study [14].”
§ Effect of non-surgical periodontal therapy on risk markers of cardiovascular disease: a systematic review and meta-analysis > Discussion > Comparison with other studies
“In this study, IL-6 levels were significantly lower in patients with periodontitis after NSPT compared to the control group.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Effect of non-surgical periodontal therapy on risk markers of cardiovascular disease: a systematic review and meta-analysis > Results > Study characteristics
“The mean age of participants ranged from 38.38 ± 9.31 to 64.00 ± 14.00 years old.”
§ Effect of non-surgical periodontal therapy on risk markers of cardiovascular disease: a systematic review and meta-analysis > Results > Study characteristics
“| Wang2020 | China | periodontitis+T2DM | Intervention group | 29 | 64.4 ± 9.3 |”
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“[28, 29].”
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · cited 1×
“…we performed sensitivity analyses by excluding studies one by one or excluding the studies in which the control group performed CPT. Egger’s test and a visual appraisal of funnel plot asymmetry were used to evaluate publication bias when at least ten RCTs were available for meta-analysis [30, 31].”
MethodRoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681 · cited 1×
“The Grading of Recommendations Assessment, Development and Evaluation (GRADE) [32] was followed to obtain the level of certainty in the body of evidence for direct estimates.”
MethodChronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915 · cited 1×
“…or spillover of inflammatory mediators from periodontal tissues to the bloodstream [4, 9], thus contributing to the systemic inflammatory burden, increasing the risk of several chronic diseases like CVD, type II diabetes mellitus (T2DM), renal diseases, cancer and neurodegenerative disorders [10].”
BackgroundNorderyd, O. M., Koch, G., Papias, A., Köhler, A. A., Helkimo, A. N., Brahm, C., Lindmark, U., Lindfors, N., Mattsson, A., Rolander, B., et al. (2015) · PubMed · Cited by 3,584
Papapanou, P. N., Sanz, M., Buduneli, N., Dietrich, T., Feres, M., Fine, D. H., Flemmig, T. F., Garcia, R., Giannobile, W. V., Graziani, F., et al. (2018) · Journal of Periodontology · doi:10.1002/jper.17-0721 · Cited by 3,202
Global Burden of Severe Periodontitis in 1990-2010: A Systematic Review and Meta-regression
Kassebaum, N. J., Bernabé, E., Dahiya, M., Bhandari, B., Murray, C. J. L., & Marcenes, W. (2014) · Journal of Dental Research · doi:10.1177/0022034514552491 · Cited by 2,209
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163 · cited 1×
“[28, 29].”
Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline
Sanz, M., Herrera, D., Kebschull, M., Chapple, I., Jepsen, S., Berglundh, T., Sculean, A., Tonetti, M. S., & Consultants, E. W. P. A. M. (2020) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13290 · Cited by 1,934 · cited 2×
“Non-surgical periodontal therapy (NSPT) primarily consists of subgingival scaling and root surface debridement to eliminate calculus and supra/subgingival biofilm [26], which is the gold-standard treatment for Stages I–III periodontitis [25].”
BackgroundPeriodontitis and cardiovascular diseases: Consensus report
Sanz, M., Marco del Castillo, A., Jepsen, S., Gonzalez‐Juanatey, J. R., D’Aiuto, F., Bouchard, P., Chapple, I., Dietrich, T., Gotsman, I., Graziani, F., et al. (2020) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13189 · Cited by 1,482
Treatment of periodontitis and endothelial function
Tonetti, M. S., D'Aiuto, F., Nibali, L., Donald, A., Storry, C., Parkar, M., Suvan, J., Hingorani, A. D., Vallance, P., & Deanfield, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063186 · Cited by 1,326
Papapanou, P. N., Sanz, M., Buduneli, N., Dietrich, T., Feres, M., Fine, D. H., Flemmig, T. F., Garcia, R., Giannobile, W. V., Graziani, F., et al. (2018) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12946 · Cited by 1,259 · cited 1×
“Periodontitis is a chronic multifactorial inflammatory disease associated with dysbiotic plaque biofilms and characterized by progressive destruction of the tooth-supporting apparatus [1].”
BackgroundCurrent Concepts in the Management of Periodontitis
Kwon, T., Lamster, I. B., & Levin, L. (2021) · International Dental Journal · doi:10.1111/idj.12630 · Cited by 1,116
European Society of Cardiology: cardiovascular disease statistics 2021
Timmis, A., Vardas, P., Townsend, N., Torbica, A., Katus, H., De Smedt, D., Gale, C. P., Maggioni, A. P., Petersen, S. E., Huculeci, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab892 · Cited by 1,102 · cited 1×
“CVD is a broad category that includes many different pathologies, including ischemic heart disease, stroke, hypertension, rheumatic heart disease, cardio-myopa-thies, and atrial fibrillation [11].”
BackgroundGlobal epidemiology of dental caries and severe periodontitis— a comprehensive review
Frencken, J. E., Sharma, P., Stenhouse, L., Green, D., Laverty, D., & Dietrich, T. (2017) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12677 · Cited by 1,079 · cited 1×
“In its severe form, periodontitis is the sixth most prevalent condition in the world and afflicts about 10% of the adult population [2, 3].”
BackgroundChapple, I. L. C., Genco, R., & on behalf of working group 2 of the joint EFP/AAP workshop (2013) · Journal of Periodontology · doi:10.1902/jop.2013.1340011 · Cited by 852
Tonetti, M. S., Van Dyke, T. E., & on behalf of working group 1 of the joint EFP/AAP workshop (2013) · Journal of Periodontology · doi:10.1902/jop.2013.1340019 · Cited by 697 · cited 2×
“…results from haematogenous dissemination of periodontal bacteria or spillover of inflammatory mediators from periodontal tissues to the bloodstream [4, 9], thus contributing to the systemic inflammatory burden, increasing the risk of several chronic diseases like CVD, type II diabetes mellitus…”
BackgroundClinical and public health implications of periodontal and systemic diseases: An overview
Genco, R. J., & Sanz, M. (2020) · Periodontology 2000 · doi:10.1111/prd.12344 · Cited by 665 · cited 1×
“One possible mechanism contributing to the relationship between comorbidities and periodontitis is the low-grade systemic inflammation caused by periodontitis, a common denominator of many chronic illnesses [8].”
BackgroundD'Aiuto, F., Gkranias, N., Bhowruth, D., Khan, T., Orlandi, M., Suvan, J., Masi, S., Tsakos, G., Hurel, S., Hingorani, A. D., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30038-x · Cited by 473
Cumpston, M. S., McKenzie, J. E., Welch, V. A., & Brennan, S. E. (2022) · Journal of Public Health · doi:10.1093/pubmed/fdac036 · Cited by 464
Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases
Schenkein, H. A., & Loos, B. G. (2013) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12060 · Cited by 454 · cited 4×
“Furthermore, several studies indicate that periodontitis patients have a more atherogenic lipid profile in the form of elevated LDL, TG, small dense LDL, as well as very low-density lipoprotein cholesterol (VLDL), along with decreased levels of HDL concentration [17, 19].”
BackgroundInfluentialMechanisms underlying the association between periodontitis and atherosclerotic disease
Schenkein, H. A., Papapanou, P. N., Genco, R., & Sanz, M. (2020) · Periodontology 2000 · doi:10.1111/prd.12304 · Cited by 440 · cited 3×
“Furthermore, several studies indicate that periodontitis patients have a more atherogenic lipid profile in the form of elevated LDL, TG, small dense LDL, as well as very low-density lipoprotein cholesterol (VLDL), along with decreased levels of HDL concentration [17, 19].”
BackgroundKebschull, M., Demmer, R. T., & Papapanou, P. N. (2010) · Journal of Dental Research · doi:10.1177/0022034510375281 · Cited by 429 · cited 1×
“…from haematogenous dissemination of periodontal bacteria or spillover of inflammatory mediators from periodontal tissues to the bloodstream [4, 9], thus contributing to the systemic inflammatory burden, increasing the risk of several chronic diseases like CVD, type II diabetes mellitus…”
BackgroundPeriodontal systemic associations: review of the evidence
Linden, G. J., Lyons, A., & Scannapieco, F. A. (2013) · Journal of Periodontology · doi:10.1902/jop.2013.1340010 · Cited by 422
Short-term Effects of Intensive Periodontal Therapy on Serum Inflammatory Markers and Cholesterol
D’Aiuto, F., Nibali, L., Parkar, M., Suvan, J., & Tonetti, M. S. (2005) · Journal of Dental Research · doi:10.1177/154405910508400312 · Cited by 416
Tonetti, M. S., Van Dyke, T. E., & working group 1 of the joint EFP/AAP workshop (2013) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12089 · Cited by 395
Periodontitis is associated with hypertension: a systematic review and meta-analysis
Muñoz Aguilera, E., Suvan, J., Buti, J., Czesnikiewicz-Guzik, M., Barbosa Ribeiro, A., Orlandi, M., Guzik, T. J., Hingorani, A. D., Nart, J., & D’Aiuto, F. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvz201 · Cited by 394
Sanz, M., Beighton, D., Curtis, M. A., Cury, J. A., Dige, I., Dommisch, H., Ellwood, R., Giacaman, R. A., Herrera, D., Herzberg, M. C., et al. (2017) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12682 · Cited by 390 · cited 2×
“Contrary to the findings of this investigation, endothelial function indicators, such as FMD and forearm blood flow (FBF), have been found to be considerably improved by periodontal treatment in periodontitis patients with CVD [82].”
BackgroundResultRole of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation
KOFLER, S., NICKEL, T., & WEIS, M. (2005) · Clinical Science · doi:10.1042/cs20040174 · Cited by 353 · cited 1×
“This is because proinflammatory stimuli significantly influence endothelial cell damage and apoptosis [81].”
BackgroundCzesnikiewicz-Guzik, M., Osmenda, G., Siedlinski, M., Nosalski, R., Pelka, P., Nowakowski, D., Wilk, G., Mikolajczyk, T. P., Schramm-Luc, A., Furtak, A., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz646 · Cited by 346
Surgical and nonsurgical periodontal therapy. Learned and unlearned concepts
Heitz‐Mayfield, L. J. A., & Lang, N. P. (2013) · Periodontology 2000 · doi:10.1111/prd.12008 · Cited by 336 · cited 1×
“Non-surgical periodontal therapy (NSPT) primarily consists of subgingival scaling and root surface debridement to eliminate calculus and supra/subgingival biofilm [26], which is the gold-standard treatment for Stages I–III periodontitis [25].”
BackgroundD'Aiuto, F., Parkar, M., Nibali, L., Suvan, J., Lessem, J., & Tonetti, M. S. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.06.018 · Cited by 332
Periodontal systemic associations: review of the evidence
Linden, G. J., Lyons, A., & Scannapieco, F. A. (2013) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12064 · Cited by 308 · cited 1×
“Accumulating evidence has shown that untreated periodontitis is associated with several systemic conditions such as cardiovascular disease (CVD) [4], diabetes [5], chronic obstructive pulmonary disease [6], and renal diseases [7].”
BackgroundOffenbacher, S., Beck, J. D., Moss, K., Mendoza, L., Paquette, D. W., Barrow, D. A., Couper, D. J., Stewart, D. D., Falkner, K. L., Graham, S. P., et al. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.080007 · Cited by 257
Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology
Reyes, L., Herrera, D., Kozarov, E., Roldán, S., & Progulske‐Fox, A. (2013) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12079 · Cited by 237 · cited 3×
“In atherothrombotic tissues, periodontal inflammation and viable bacteria have been found [18, 83, 84].”
BackgroundEngebretson, S., & Kocher, T. (2013) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12084 · Cited by 236
Ide, M., McPartlin, D., Coward, P. Y., Crook, M., Lumb, P., & Wilson, R. F. (2003) · Journal of Clinical Periodontology · doi:10.1034/j.1600-051x.2003.00282.x · Cited by 229
Evidence that periodontal treatment improves biomarkers and CVD outcomes
D'Aiuto, F., Orlandi, M., & Gunsolley, J. C. (2013) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12061 · Cited by 226
Vidal, F., Figueredo, C. M. S., Cordovil, I., & Fischer, R. G. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.080471 · Cited by 200
Periodontal diseases and association with atherosclerotic disease
Herrera, D., Molina, A., Buhlin, K., & Klinge, B. (2020) · Periodontology 2000 · doi:10.1111/prd.12302 · Cited by 191 · cited 3×
“In atherothrombotic tissues, periodontal inflammation and viable bacteria have been found [18, 83, 84].”
BackgroundReducing the risk of CVD in patients with periodontitis
Genco, R. J., & Van Dyke, T. E. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.120 · Cited by 182
Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases
Schenkein, H. A., & Loos, B. G. (2013) · Journal of Periodontology · doi:10.1902/jop.2013.134006 · Cited by 175
Higashi, Y., Goto, C., Hidaka, T., Soga, J., Nakamura, S., Fujii, Y., Hata, T., Idei, N., Fujimura, N., Chayama, K., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.037 · Cited by 173
Chen, L., Luo, G., Xuan, D., Wei, B., Liu, F., Li, J., & Zhang, J. (2012) · Journal of Periodontology · doi:10.1902/jop.2011.110327 · Cited by 158
Sharma, P., Dietrich, T., Ferro, C. J., Cockwell, P., & Chapple, I. L. C. (2016) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12502 · Cited by 155 · cited 1×
“Accumulating evidence has shown that untreated periodontitis is associated with several systemic conditions such as cardiovascular disease (CVD) [4], diabetes [5], chronic obstructive pulmonary disease [6], and renal diseases [7].”
BackgroundPeriodontal therapy and cardiovascular risk
Orlandi, M., Graziani, F., & D'Aiuto, F. (2020) · Periodontology 2000 · doi:10.1111/prd.12299 · Cited by 155 · cited 1×
“It has been proved that there is an association between periodontitis and CVD, and this relation has been reported to be independent of other risk factors such as age, gender, dyslipidemia, hypertension, diabetes, and lifestyle factors such as smoking [12, 13].”
BackgroundEvidence that periodontal treatment improves biomarkers and CVD outcomes
D’Aiuto, F., Orlandi, M., & Gunsolley, J. C. (2013) · Journal of Periodontology · doi:10.1902/jop.2013.134007 · Cited by 139 · cited 2×
“Patients with severe periodontitis had higher blood neutrophil counts and pro-inflammatory mediator levels (such as IL-1, IL-6, CRP, and fibrinogen) compared to healthy controls [14–17], which were associated with a higher cardiovascular risk [18].”
BackgroundResultLópez, N. J., Quintero, A., Casanova, P. A., Ibieta, C. I., Baelum, V., & López, R. (2012) · Journal of Periodontology · doi:10.1902/jop.2011.110227 · Cited by 133
New Standards for Systematic Reviews Incorporate Population Health Sciences
Nasser, M. (2020) · American Journal of Public Health · doi:10.2105/ajph.2020.305609 · Cited by 123
H. Bokhari, S. A., Khan, A. A., Butt, A. K., Azhar, M., Hanif, M., Izhar, M., & Tatakis, D. N. (2012) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2012.01942.x · Cited by 119
Rafferty, B., Jönsson, D., Kalachikov, S., Demmer, R. T., Nowygrod, R., Elkind, M. S. V., Bush, H., & Kozarov, E. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02373.x · Cited by 106 · cited 1×
“In atherothrombotic tissues, periodontal inflammation and viable bacteria have been found [18, 83, 84].”
BackgroundFang, F., Wu, B., Qu, Q., Gao, J., Yan, W., Huang, X., Ma, D., Jin, Y., Chen, T., Liu, F., et al. (2015) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12411 · Cited by 91
Zhou, Q., Xia, W., Ren, J., Yu, B., Tong, X., Chen, Y., Chen, S., Feng, L., Dai, J., Tao, J., et al. (2017) · Journal of Periodontology · doi:10.1902/jop.2017.160447 · Cited by 89
Fu, Y., Li, X., Xu, H., Gong, Y.-Q., & Yang, Y. (2015) · Clinical Oral Investigations · doi:10.1007/s00784-015-1621-2 · Cited by 83
Masi, S., Orlandi, M., Parkar, M., Bhowruth, D. J., Kingston, I., O’Rourke, C., Virdis, A., Hingorani, A. D., Hurel, S. J., Donos, N., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.019 · Cited by 82
Holtfreter, B., Empen, K., Gläser, S., Lorbeer, R., Völzke, H., Ewert, R., Kocher, T., & Dörr, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084603 · Cited by 79 · cited 1×
“Additionally, there is evidence from various studies that individuals with periodontitis have a higher prevalence of subclinical CVD, which is characterized by significant arterial stiffness (assessed by pulse wave velocity [PWV]) [20] and endothelial dysfunction [21].”
BackgroundCaúla, A. L., Lira‐Junior, R., Tinoco, E. M. B., & Fischer, R. G. (2014) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12290 · Cited by 79
Beneficial Effects of Periodontal Treatment on Metabolic Control of Hypercholesterolemia
Oz, S. G., Fentoglu, O., Kilicarslan, A., Guven, G. S., Tanrover, M. D., Aykac, Y., & Sozen, T. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e31802fa327 · Cited by 79
Luthra, S., Orlandi, M., Hussain, S. B., Leira, Y., Botelho, J., Machado, V., Mendes, J. J., Marletta, D., Harden, S., & D'Aiuto, F. (2023) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13709 · Cited by 74 · cited 1×
“A recent meta-analysis that focused on CRP values alone concluded that treat-ment of periodontitis reduces serum CRP levels (up to 6 months follow-up), and no treatment effect was observed at 12 months or beyond [79].”
BackgroundKamil, W. A., Habashneh, R. A., Khader, Y. S., Al-Bayati, L. H. A., & Taani, D. Q. (2011) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2011.01380.x · Cited by 68
Chou, S., Tung, Y., Lin, Y., Wu, L., Lin, C., Liou, E. J., Chang, C., Kung, S., & Chu, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130807 · Cited by 67
Montenegro, M. M., Ribeiro, I. W. J., Kampits, C., Saffi, M. A. L., Furtado, M. V., Polanczyk, C. A., Haas, A. N., & Rösing, C. K. (2019) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13085 · Cited by 67
Sun, W., Chen, L., Zhang, S., Ren, Y., & Qin, G. (2010) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2010.08.001 · Cited by 65
Periodontitis and arterial stiffness: a systematic review and meta‐analysis
Schmitt, A., Carra, M. C., Boutouyrie, P., & Bouchard, P. (2015) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12467 · Cited by 65 · cited 1×
“Additionally, there is evidence from various studies that individuals with periodontitis have a higher prevalence of subclinical CVD, which is characterized by significant arterial stiffness (assessed by pulse wave velocity [PWV]) [20] and endothelial dysfunction [21].”
BackgroundKapellas, K., Maple-Brown, L. J., Jamieson, L. M., Do, L. G., O’Dea, K., Brown, A., Cai, T. Y., Anstey, N. M., Sullivan, D. R., Wang, H., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03359 · Cited by 64
Wehmeyer, M. M. H., Kshirsagar, A. V., Barros, S. P., Beck, J. D., MOSS, K. L., Preisser, J. S., & Offenbacher, S. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.10.021 · Cited by 59
Li, X., Tse, H. F., Yiu, K. H., Li, L. S. W., & Jin, L. (2011) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2010.01651.x · Cited by 57
Taylor, B., Tofler, G., Morel‐Kopp, M., Carey, H., Carter, T., Elliott, M., Dailey, C., Villata, L., Ward, C., Woodward, M., et al. (2010) · European Journal Of Oral Sciences · doi:10.1111/j.1600-0722.2010.00748.x · Cited by 54
Hada, D. S., Garg, S., Ramteke, G. B., & Ratre, M. S. (2015) · Journal of Periodontology · doi:10.1902/jop.2015.150249 · Cited by 54
Periodontal treatment on patients with cardiovascular disease: Systematic review and meta-analysis
Roca-Millan, E., Gonzalez-Navarro, B., Sabater-Recolons, M., Mari-Roig, A., Jane-Salas, E., & Lopez-Lopez, J. (2018) · Medicina Oral Patología Oral y Cirugia Bucal · doi:10.4317/medoral.22725 · Cited by 54 · cited 3×
“In contrast, the majority of previously relevant meta analyses only included periodontitis patients with specific systemic health conditions, such as CVD [75], CAD [76], hypertension [77] and diabetes [78].”
ResultSaffi, M. A. L., Rabelo‐Silva, E. R., Polanczyk, C. A., Furtado, M. V., Montenegro, M. M., Ribeiro, I. W. J., Kampits, C., Rösing, C. K., & Haas, A. N. (2018) · Oral Diseases · doi:10.1111/odi.12909 · Cited by 53
Sharma, S., Sridhar, S., McIntosh, A., Messow, C.-M., Aguilera, E. M., Del Pinto, R., Pietropaoli, D., Gorska, R., Siedlinski, M., Maffia, P., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105511 · Cited by 53 · cited 2×
“In contrast, the majority of previously relevant meta analyses only included periodontitis patients with specific systemic health conditions, such as CVD [75], CAD [76], hypertension [77] and diabetes [78].”
ResultMontero, E., López, M., Vidal, H., Martínez, M., Virto, L., Marrero, J., Herrera, D., Zapatero, A., & Sanz, M. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14131 · Cited by 50
Koppolu, P., Durvasula, S., Palaparthy, R., Rao, M., Sagar, V., Reddy, S. K., & Lingam, S. (2013) · Pan African Medical Journal · doi:10.11604/pamj.2013.15.92.2326 · Cited by 48
Effect of Periodontal Treatment on HbA1c among Patients with Prediabetes
Kocher, T., Holtfreter, B., Petersmann, A., Eickholz, P., Hoffmann, T. K., Kaner, D., Kim, T., Meyle, J., Schlagenhauf, U., Doering, S., et al. (2018) · Journal of Dental Research · doi:10.1177/0022034518804185 · Cited by 47
Javed, F., Ahmed, H., Mehmood, A., Bain, C., & Romanos, G. (2014) · Clinical Oral Investigations · doi:10.1007/s00784-014-1185-6 · Cited by 46
Seinost, G., Horina, A., Arefnia, B., Kulnik, R., Kerschbaumer, S., Quehenberger, F., Muster, V., Gütl, K., Zelzer, S., Gasser, R. N. A., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.09.019 · Cited by 42
Skilton, M. R., Maple-Brown, L. J., Kapellas, K., Celermajer, D. S., Bartold, P. M., Brown, A. D. H., O’Dea, K., Slade, G. D., & Jamieson, L. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-729 · Cited by 41
Treating periodontal disease in patients with myocardial infarction: A randomized clinical trial
Lobo, M. G., Schmidt, M. M., Lopes, R. D., Dipp, T., Feijó, I. P., Schmidt, K. E. S., Gazeta, C. A., Azeredo, M. L., Markoski, M., Pellanda, L. C., et al. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.08.012 · Cited by 40
Tawfig, A. (2015) · Journal of International Society of Preventive and Community Dentistry · doi:10.4103/2231-0762.156524 · Cited by 31
Gunupati, S., Chava, V. K., & Krishna, B. P. (2011) · Journal of Periodontology · doi:10.1902/jop.2011.110002 · Cited by 31
Doke, M., Komagamine, Y., Kanazawa, M., Iwaki, M., Suzuki, H., Miyazaki, Y., Mizuno, T., Okayasu, K., & Minakuchi, S. (2021) · BMC Oral Health · doi:10.1186/s12903-020-01373-3 · Cited by 29
Ferlazzo, N., Currò, M., Isola, G., Maggio, S., Bertuccio, M. P., Trovato-Salinaro, A., Matarese, G., Alibrandi, A., Caccamo, D., & Ientile, R. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43020051 · Cited by 27 · cited 1×
“CVD is inseparable from endothelial inflammation, and severe endothelial dysfunction is a significant factor affecting adverse cardiovascular events [80].”
BackgroundWang, Y., Liu, H. N., Zhen, Z., Pelekos, G., Wu, M. Z., Chen, Y., Tonetti, M. S., Tse, H., Yiu, K. H., & Jin, L. (2020) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13291 · Cited by 25
Rapone, B., Ferrara, E., Qorri, E., Dipalma, G., Mancini, A., Corsalini, M., FABBRO, M. D., Scarano, A., Tartaglia, G. M., & Inchingolo, F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144173 · Cited by 25
Periodontal disease and chronic kidney disease among Aboriginal adults; an RCT
Jamieson, L., Skilton, M. R., Maple-Brown, L. J., Kapellas, K., Askie, L. M., Hughes, J., Arrow, P., Sajiv, C., Fernandes, D. K., Pawar, B., et al. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0169-3 · Cited by 24
Periodontitis and Cardiovascular Disease: Periodontal Treatment Lowers Plasma Cholesterol
Lösche, W. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e318038fa4d · Cited by 19
(2019) · PubMed · Cited by 17
Luthra, S., Orlandi, M., Hussain, S. B., Leira, Y., Botelho, J., Machado, V., Mendes, J. J., Marletta, D., Harden, S., & D'Aiuto, F. (2021) · doi:10.2139/ssrn.3807963 · Cited by 12
Liu, C., Shi, F., Li, W., & Chen, J. (2022) · Medicina Oral Patología Oral y Cirugia Bucal · doi:10.4317/medoral.25514 · Cited by 11 · cited 1×
“In contrast, the majority of previously relevant meta analyses only included periodontitis patients with specific systemic health conditions, such as CVD [75], CAD [76], hypertension [77] and diabetes [78].”
Result
Cited by
Guo, J.-J., Hang, Q.-Q., Xu, T., Liang, W.-X., Gao, J.-K., Ou, H.-B., Jiang, F.-Z., Qiu, X.-C.-H., Tian, Z.-Z., Zhang, Y., et al. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02619-1 · Cited by 17
“…further demonstrated that both central adiposity and systemic inflammation partially explain this relationship, aligning with evidence that visceral fat–driven cytokines (e.g., IL-6, TNF-α) contribute to systemic inflammation involved in both cardiovascular and periodontal diseases [33, 34].”
Xiao, Y., Gong, B., Li, J., & Xu, N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1640904 · Cited by 25
“Authoritative systematic reviews, including those by Cochrane, have consistently concluded that the available evidence is of very low certainty and is insuf fi cient to support or refute the hypothesis that periodontal therapy prevents the occurrence or recurrence of CVD events (83, 84).”
Oral microbiome contributions to metabolic syndrome pathogenesis
Yue, Z., Fan, Y., Shan, G., & Chen, X. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1630828 · Cited by 15
Su, Y., Cao, Y., Bing, X., Chen, C., Yan, H., Zhao, H., Wang, Y., Liu, S., Xie, Y., Li, C., et al. (2025) · Journal of Evidence Based Dental Practice · doi:10.1016/j.jebdp.2025.102136 · Cited by 8
Meng, R., Xu, J., Fan, C., et al. (2024) · BMC Oral Health · doi:10.1186/s12903-024-04559-1 · Cited by 3
Self-citation
Metadata
- Authors
- Meng, R., Xu, J., Fan, C., Liao, H., Wu, Z., & Zeng, Q.
- Affiliations
- Guangxi Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Corresponding author
- Liao, Haiqing
- Zeng, Qixin
- Venue
- BMC Oral Health
- Published
- 2024-06-14
- Volume
- 24
- Issue
- 1
- Pages
- 692-692
- ISSN
- 1472-6831 (ISSN-L)
- PMC
- PMC11177403
- OpenAlex
- W4399679549
- Cited by
- 26
- References
- 92
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 1
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-07-18)
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Oral Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- the National Natural Science Foundation of China (No. 82101016)
- the Guangxi Science and Technology Base and Talent Special Project (No. GuikeAD21220008)
- the open project of Guangxi Key Laboratory of the Rehabilitation and Reconstruction for Oral and Maxillofacial Research (No. GXKLRROM2103)
- the Nanning Qingxiu district science and technology plan project (No. KY017005)
- Topics
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Health Sciences › Dentistry › General Dentistry › Dental Research and COVID-19
- Keywords
- non-surgical periodontal therapy, periodontitis, cardiovascular risk markers, C-reactive protein, interleukin-6, systolic blood pressure, inflammatory markers, lipoproteins, flow-mediated dilation, cardiovascular inflammation
- MeSH terms
- Heart Disease Risk Factors, Blood Pressure, C-Reactive Protein, Cardiovascular Diseases, Humans, Periodontitis, Risk Factors, Biomarkers, Interleukin-6, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.